Oral contraceptive plus spironolactone safely addresses androgen excess in PCOS
PCOS women treated with a combination oral contraceptive with spironolactone were not at increased risk for metabolic or cardiovascular complications, according to findings published in theEuropean Journal of Endocrinology.Healio
Source: Society for Endocrinology - Category: Endocrinology Source Type: news
More News: Cardiology | Cardiovascular | Endocrinology | Heart | Polycystic Ovary Syndrome | Spironolactone | Women